Clinical Positron Imaging · 1999 · 16 citations · 11 references
MedicineNuclear MedicineRadiologyDiagnostic ImagingDiagnostic RadiologyMolecular ImagingHead ImagingMedical ImagingPositron Emission Tomography18F-fluorodeoxyglucose Imaging18F-fluorodeoxyglucose Positron Emission TomographyFluorine-18 Fluorodeoxyglucose Positron Emission TomographyFluorine-18 LabelingFluorine-19 Magnetic Resonance Imaging
11
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.
Edward F. Patz, Val J. Lowe, John M. Hoffman et al. · Radiology · 1993 · 512 citations
Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.
Florian Moog, Markus Bangerter, C. G. Diederichs et al. · Radiology · 1997 · 312 citations
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
Carl K. Hoh, John A. Glaspy, Peter Rosen et al. · PubMed · 1997 · 264 citations
Medicine, Nuclear Medicine, Oncology +17
PET scanning and the human immunodeficiency virus-positive patient.
Michael O’Doherty, Sally F. Barrington, Meg Campbell et al. · PubMed · 1997 · 214 citations
Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase.
Annette Rempel, Saroj P. Mathupala, C. A. Griffin et al. · PubMed · 1996 · 179 citations